Patent · US Active

KIF11 and method for diagnosing non-small cell lung cancer

US7972772B2 · kind B2 · utility

15Cited by

7References

7Claims

0Family size

Assignee

ONCOTHERAPY SCIENCE, INC. · JP

Inventors

Yusuke Nakamura · Bunkyo, JP
Yataro Daigo · Tokyo, JP
Shuichi Nakatsuru · Kawasaki, JP

Key dates

Filing date	Feb 4, 2010
Grant date	Jul 5, 2011
Priority date	—
Expiry date	Feb 4, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/158
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are methods for detecting non-small cell lung cancer (NSCLC) using differentially expressed genes KIF11, GHSR1b, NTSR1, and FOXM1. Also disclosed are methods of identifying compounds for treating and preventing NSCLC, based on the interaction between KOC1 and KIF11, or NMU and GHSR1b or NTSR1.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.